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LETTERS TO THE EDITOR 
Dual-Chamber Pacing in Dilated 
Cardiomyopathy: Insuikient Sample Size, 
Hetemneous Popuiatioa and Inappropriate 
End Poiot May Lead to Erroneous 
conchlsions 
We readwith great interest the report by Gold et al. (1) u~tt-~ Gctober 
issue of the Ioumal, whii conch&d discouraging the “routine use of 
pacemaker implantation with short atrioventricuiar (AV) .delay as a 
primary treatment of heart faihue in patients without standard ar- 
rhythmic indiitions.” However, it is our opinion that such strong 
(9 of 12 sub&s were able to complete randomization 2nd fc’iawuo) 
bad coronary artery dii) and that most patients (83%) ‘were in 
New York Heart Association timctional class III. Unfortunately, no 
inbrmation on the extent and severity of the cotonary artery disease 
were presented nor WI tbc investigation of stunned or hibernating 
my- or the presence of concomitant disease (i.e., diabetes, 
duonic obstructk puhuonary disease). ‘Ibis information would be of 
great interest in view of the results of this study (1). Thw the patient 
population sehxted by Gold et al. profotmdly diiers from that of 
Hochleitner et al. (2) or ours (3), whii inch&d mainly patients with 
severe end-stage heart failure as documented by the use of intravenous 
hmtmpes Moreover, in both series the population was consistently 
homogenous with regard to etiology in that Hoddeitner et al. (2) 
descrii pttients with idiopathic dilated cardiomyopathy, and we (3) 
have induded two patients with severe coronary artery dii. 
Anotbcr snrprisii Wing was the lefi vwtricular e.jection fraction 
~WIaodMIDpacio&apreportedinFigure3ofGokletal.(l). 
In light of the prevalent underlying etiology of theii study (coronary 
artery disease), the iaclt of major improvement in such a short period 
of pacing is nut surprising. In addhion, questmnable data were 
presented becaw apparently results from only 8 of 12 patients were 
plotted (Fii 3 [l]). Furthermore, the data plotted demonstrated 
subatunial improvement in left ventriadar ejection fraction when 
patientv were paced in VDD mode, whiih was >15% in some patients 
(e.g., the second patient in Figure 3 whose left ventricular ejectiou 
fraclion changed from -22% to 26% (i.e., an 18% improvement). 
However, Gold et al. did not extensively comment on this point but 
only briegy reported that “‘Ihere was not significant improvement in 
ejwtion fractionwitbshortAVdelaypacingbecausethemeanejection 
fmction was 18 + 4% in VVI mode and 16 + 6% in VDD mode. 
Morwver, no patient had an improvement X% with VDD pacing 
conyed with Wl cord paciop.” Because modihcation of left 
ven@m&rejectionbactionwaaoneendpointofthestudy,wewould 
appreciatefurtberSghtsintothedatad&epan&andsome 
patlmw cxpbmation for the worsen& of the left ventricstlar 
ejwtion fraction during VDD compared with WI stimulation. 
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varied. In fact, by study design they required that cardiac output at 
each AV delay should bc evaluated in triplicate at least or more if drift 
in baseline occured, which could expose a very sick heart to consistent 
liquid overloading in a crucial recovery phase after the implantation. In 
addition, because 10 to 15 min of steady state before and after any 
measurement was required, this implies an acute study duration of at 
least I h. In our experience, a subtle spontaneous drift with continuous 
undulations of the baseline (sometimes considerably large) occurs as a 
result of intrinsic autonomic tone variability the hemodynamic conse- 
quences of which are further dramatically influenced by long duration 
of the study period and liquid infusion. Furthermore, the large 
interindividual variability, as xcently demonstrated by Niiiura et al. 
(4), implies that anaiysis of cumulative data (e.g., cardiac output or left 
ventricular ejection fraction) rather than individual data could be 
considerably misleading. Finally, many recent data indicate that the 
use of a single AV delay is nnt anpromiate and that it is nxasary to 
tailor the AV delay and pacing site to maximize the benefit of pacing 
in each patient (5). 
1-i -wrrtusinn, we as “belivers” in pacing as additional therapy for 
congestive heart failure, at least in a subset of patients, accept the 
conclusion of Leinbach (6) to not dose the door to “,yeryone,” and we 
welcome prospective studies to identify subsets of patients who can 
poten!ially benefit from such a cheap and widely available therapy as 
pacing. 
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Our study (1) was designed to test the bypoUt& that dual-chamber 
padng with a short atrioventricular (AV) delay improves acute ;lemo 
dynamic variables and causes sustained dinicai benefit in patients with 
advancedchiotticconge&eheartfaihtre.Assn&toourknowledge 
~~~~~,~-~~~~~~ 
inthispatientpopdat&Themotiv&mforourstudywasthe 
~~~~~~ reportsoftbcfavor- 
